CHM_MSKCC Profile
CHM_MSKCC

@CHM_MSKCC

Followers
803
Following
130
Media
24
Statuses
191

Center for Hematologic Malignancies @MSKCC. Accelerating biology & treatment of #BloodCancers.

New York, NY
Joined September 2017
Don't wanna be here? Send us removal request.
@CHM_MSKCC
CHM_MSKCC
1 year
C
0
0
0
@TaylorJ_MD
Taylor Lab UM
4 years
That’s an amazing illustration! You’ve got great talent. And of course congrats to @AbdelWahablab & @bradleybio!
@munafomarzia
Marzia Munafò
4 years
Harnessing #RNA splicing vs cancer🔥 A new study @CellCellPress I had the pleasure to illustrate shows splicing modulation results in the production of neoantigens and thus elicits anti-tumour immunity! Kudos @bradleybio @fredhutch @AbdelWahablab @SXLuLab @ejdeneef @jdthomaslab..
1
1
11
@AbdelWahablab
Abdel-Wahab Lab
4 years
Excited to share our collaboration w/ @bradleybio demonstrating that pharmacologic modulation of splicing induces immunogenic neoantigens and augments response to checkpoint blockade. Jointly led by @SXLuLab, @ejdeneef, @jdthomaslab. Out today in @Cell: https://t.co/kKWVNjnv9C
Tweet card summary image
cell.com
By provoking production of “neoantigens” that are recognized by immune cells, drugs that modulate RNA splicing can enhance cancer immunotherapy.
22
53
240
@KharasLab
Michael Kharas MSK
4 years
TOMORROW IS THE DEADLINE FOR FASEB 2021 ABSTRACTS JUNE 25TH 2021 FASEB HEME MALIGNANCIES!!! SPEAKER SLOTS, TEASER TALKS, AND POSTERS ALL STILL OPEN!! https://t.co/xAXvgS1Mnm
2
6
22
@CHM_MSKCC
CHM_MSKCC
4 years
Check out this Excellent work from @KharasLab and others out @Cancer_Cell! Congrats to all!
@KharasLab
Michael Kharas MSK
4 years
So excited and congrats to Yuanming Cheng @kharasLab, Wei Xie (Patel Lab), and all of our collaborators on their paper uncovering the role for the m6A reader YTHDC1 in AML and its ability to form dynamic nuclear condensates! https://t.co/f3bEuDrORJ @Cancer_Cell @CHM_MSKCC
0
0
3
@KentsisResearch
Kentsis Research Group
5 years
Research Shows How Common Feature of Blood Cancers Can Be Targeted
Tweet card summary image
mskcc.org
Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
2
12
56
@CLLAdvocates
CLL Advocates Network
5 years
Please RT & join us on 11th Feb 4-5:30pm CET our extensive panel of experts discuss COVID-19 vaccination and immune challenges for leukemia patients. This webinar is co-hosted by @CLLAdvocates and @AcuteLeuk FREE to register here: https://t.co/jKmLOo0i8l
1
14
22
@RichardKoche
Richard Koche
5 years
Very happy to see our paper on enhancer hijacking determining MYCN amplicon architecture in neuroblastoma chosen for an Editor's Highlight. If you're attending #ANR2021, it's great timing to see this presented w/@KHelmsauer and @anton_gh tomorrow! https://t.co/j6o6ubqszK
Tweet card summary image
nature.com
On this page we provide a snapshot of some of the most exciting works recently published in Nature Communications in cancer research. We cover all aspects of ...
0
7
25
@KentsisResearch
Kentsis Research Group
5 years
A new year for new science and a new science publishing model: Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia ☛
0
3
17
@CHM_MSKCC
CHM_MSKCC
5 years
Sloan Kettering Institute Scientists Solve a 100-Year-Old Mystery about Cancer | Memorial Sloan Kettering Cancer Center
Tweet card summary image
mskcc.org
Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.
0
4
9
@LoweLabMSKCC
Lowe Lab
5 years
Congratulations to postdoc @ScottMillmanMD on being selected by @ASH_hematology to receive an ASH Scholar Award! Scott will investigate metabolic gene dependencies in #AML. https://t.co/7H8S1Tyf29 #ASHAwards
0
1
15
@MskccCMO
MSKCC Center for Molecular Oncology (CMO)
5 years
Amidst the many firsts of 2021, we present our first @MskccCMO #Twinterview of the year, featuring Sarah Phillips Suehnholz @SPSuehnholz of @OncoKB and Andrea Farina @RomanoNyc of @genomics212!
0
6
16
@FlowMskcc
flowMSKCC
5 years
Folkss, the latest #OpenFlow session (with amazing @CrickTraining) is on YouTube! "Full Spectrum #FlowCytometry Part II - Panel Design & Troubleshooting" using @CytekBio #Aurora. check this out: https://t.co/YTOWAIetul #flowcyto #flownerds #science #flowedu
0
3
5
@TheDoctorIsVin
Aaron Viny
5 years
Very grateful for the support of @columbiacancer @CSCIColumbia @ColumbiaGenDev and @ASH_hematology. I stand on the shoulders of giants @rosslevinemd.
10
1
82
@CHM_MSKCC
CHM_MSKCC
5 years
Check out the press release here👇👇👇 https://t.co/hRn3cxCPGb
0
0
0
@CHM_MSKCC
CHM_MSKCC
5 years
Congrats @diunguyen_vn_uk @KharasLab on receiving the ASH Scholar Award! Her work will uncover differential translational programs in AML ➡️investigating mechanisms underlying the differential regulation of MSI2 in AML propagating LSCs & shed light on potential therapies. 🙌👏
2
1
8
@BCD_AACR
Blood Cancer Discovery
5 years
Just published #OnlineFirst: A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in #Myeloid Neoplasms. @CCLRI @ClevelandClinic @leukaemielabor @LurieCancer @SylvesterCancer #MPN https://t.co/UQaQcZxjBz
0
5
23
@PapaemmanuilLab
Elli Papaemmanuil, PhD
5 years
I could not be prouder for this paper https://t.co/KRMm2SdNug "Isabl, a digital biobank for processing multimodal patient data" published this week in BMC Bioinformatics led by @jsmedmar ( https://t.co/vkpwTv2uKV). A thread as to why this is important.1/
7
17
98
@CHM_MSKCC
CHM_MSKCC
5 years
👇🏼👇🏼👇🏼
0
0
6